Cannabinoid Receptor 2 Signaling In Neurodegenerative Disorders: From Pathogenesis To A Promising Therapeutic Target

Alzheimer's Disease Parkinson's Disease Cognitive Function (Decreasing)

Key Findings

CB2 activation may be a valuable and potential alternative treatment strategy to slow the progression and reduce the symptoms of cognitive decline in AD. CB2 receptors play an important role in the pathophysiology of PD and that their activation with selective agonist may lead to neuroprotective effect in the neurodegenerative processes of PD.

Information and Links


Link: Cannabinoid Receptor 2 Signaling In Neurodegenerative Disorders: From Pathogenesis To A Promising Therapeutic Target

Year: 2017

DOI: 10.3389/fnins.2017.00030


Ratings

(How Ratings Work)

Alzheimer's Disease — 3


Likely probability of the efficacy of cannabis for treatment of Alzheimer's Disease according to the results found in this study.

Parkinson's Disease — 3


Likely probability of the efficacy of cannabis for treatment of Parkinson's Disease according to the results found in this study.

Cognitive Function (Decreasing) — 3


Likely probability of the efficacy of cannabis for treatment of Cognitive Function (Decreasing) according to the results found in this study.

Drugs Used

CB2 receptors